141 related articles for article (PubMed ID: 8557519)
1. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation.
Ryffel B; Willcocks JL; Brooks N; Woerly G
Immunopharmacology; 1995 Sep; 30(3):199-207. PubMed ID: 8557519
[TBL] [Abstract][Full Text] [Related]
2. Effect of rapamycin on the expression of the IL-2 receptor (CD25).
Woerly G; Brooks N; Ryffel B
Clin Exp Immunol; 1996 Feb; 103(2):322-7. PubMed ID: 8565319
[TBL] [Abstract][Full Text] [Related]
3. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
5. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
Mattila PS
Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
[No Abstract] [Full Text] [Related]
6. Autocrine and paracrine regulation of human T cell IL-10 production.
Cohen SB; Parry SL; Feldmann M; Foxwell B
J Immunol; 1997 Jun; 158(12):5596-602. PubMed ID: 9190906
[TBL] [Abstract][Full Text] [Related]
7. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
[No Abstract] [Full Text] [Related]
8. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
Teutsch M; Higer M; Wang D; Wortis HW
Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin.
Luo H; Chen H; Daloze P; St-Louis G; Wu J
Clin Exp Immunol; 1993 Nov; 94(2):371-6. PubMed ID: 8222329
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
[TBL] [Abstract][Full Text] [Related]
13. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
14. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
15. Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation.
Miyamoto S; Safer B
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):803-12. PubMed ID: 10585867
[TBL] [Abstract][Full Text] [Related]
16. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
Sawada S; Suzuki G; Kawase Y; Takaku F
J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
[TBL] [Abstract][Full Text] [Related]
18. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
Chae DW; Nosaka Y; Strom TB; Maslinski W
J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits the in vitro release of soluble interleukin-2 receptor by activated peripheral blood mononuclear cells (PBMC) independently of the mode of activation.
Degiannis D; Hornung N
Int J Immunopharmacol; 1995 Jul; 17(7):593-6. PubMed ID: 8586487
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
Rincón M; Tugores A; López-Rivas A; Silva A; Alonso M; De Landázuri MO; López-Botet M
Eur J Immunol; 1988 Nov; 18(11):1791-6. PubMed ID: 2849551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
